Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Moodys
Accenture
Colorcon
Federal Trade Commission
Boehringer Ingelheim
Chubb
Teva
Cerilliant

Generated: November 13, 2018

DrugPatentWatch Database Preview

Protamine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for protamine sulfate and what is the scope of protamine sulfate patent protection?

Protamine sulfate is the generic ingredient in one branded drug marketed by Fresenius Kabi Usa, Lilly, Pharmacia And Upjohn, and West-ward Pharms Int, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for protamine sulfate. One supplier is listed for this compound.

Summary for protamine sulfate
Pharmacology for protamine sulfate

US Patents and Regulatory Information for protamine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 089454-001 Apr 7, 1987 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 007413-002 Aug 2, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 007413-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Moodys
Accenture
Colorcon
Federal Trade Commission
Boehringer Ingelheim
Chubb
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.